The PETITE-DTG study evaluated the dosing and safety of dolutegravir (DTG) in neonates born to mothers living with HIV. The study assessed a pediatric dispersible tablet and an oral film, finding the dosing strategy to be safe and effective. The PETITE PLATFORM aims to accelerate neonatal dosing recommendations for ARVs, with the goal of expanding access to the latest advancements in HIV care for newborns. The study showed high levels of acceptability for both DTG formulations, potentially improving HIV prevention and treatment options for neonates.
Full Article
Government scrambles to address viral pothole controversy
The Zimbabwean government faces criticism over neglect of the Bulawayo-Victoria Falls Highway, as a viral image shows individuals posing in a massive pothole, highlighting the road's deteriorating state. Travelers and motorists have raised concerns about the hazardous conditions, leading to increased accidents and vehicle damage. Despite government denials, repair efforts are underway in partnership with Bitumen World to address urgent sections of the highway, while opposition politician Gift Ostallos Siziba condemns the extensive damage and...
Read more